/Investor DB

Morgenthaler

Venture capital

Portola Valley · Pre-Seed–Series C · 8 people tracked

Also known as MORGENTHALER MANAGEMENT CORPORATION

Find your way into Morgenthaler

Sign up to see every warm intro you have to Morgenthaler

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Morgenthaler team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Morgenthaler is a venture capital and private equity firm that has focused on building valuable companies for over 40 years.

Invests inBiotechSector AgnosticPortola ValleyUnited States

Source: firm website, verified Sep 29, 2026.

Stage
Pre-Seed–Series C
HQ
Portola Valley, CA, US
Instruments
Equity
Founded
1982
Private fund assets
$48.5M
VC funds
1
Tracked investments
40
Unicorns
3
IPOs
2
Acquisitions
3

Team · 8 people

from the firm's website & curated & public directories

Founder mafia

5 people who came through Morgenthaler went on to found or lead other companies.

What they invest in

from 27 of 40 portfolio companies

Healthtech ×14Medical Devices ×9AI & Machine Learning ×5Biotech ×5SaaS ×5Enterprise Software ×4Hardware ×4Fintech ×3

HQs:United States×20Australia×1Brazil×1

Investments · 40 tracked

founders shown can be your intro path

By year:2023 · 12020 · 12018 · 12015 · 32014 · 22013 · 22012 · 12011 · 12009 · 22008 · 12005 · 116 dated

Doximitydoximity.comin𝕏NYSE: DOCS

Doximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings.

AI & Machine LearningDigital HealthHealthtechSaaSSocialSan Francisco, US

Jeff Tangney(Founder)Dr. Nate Gross(Co-founder)Nate Gross(Founder)Shari Buck(Founder)

Co-investorsEmergence Capital PartnersCanvas VenturesThreshold Ventures

EBR Systemsebrsystemsinc.comin𝕏OTC: EBRCZSeries B · Oct 2005 · $21M

EBR Systems develops the WiSE cardiac pacing system, a leadless and physiologic medical device for treating heart failure patients.

HealthtechMedical DevicesSilicon Valley, AU

Parker Willis(Executive Officer)inAllan Will(Executive Chair)inJohn McCutcheon(President, Chief Executive Officer)inMark Cowan(Executive Officer)inStephen O'Conner(Executive Officer)Richard Riley(Executive Officer)

Co-investorsAscension VenturesEmergent Medical Partners, LLPRunway Growth CapitalSplit Rock Partners

Ardianmedtronicrdn.comSeries C · Mar 2009 · $47M

Co-investorsEmergent Medical Partners, LLP

Black Ducksynopsys.comin𝕏Aug 2014

Synopsys provides design automation tools and intellectual property for semiconductor and electronics companies to develop smart, connected devices.

Developer ToolsEnterprise SoftwareSemiconductorsBurlington, US

Doug Levin(Founder)Aart de Geus(Founder)inStephen N. Gregorio(Executive Officer)Philip B. Granof(Executive Officer)William NMN Ledingham(Executive Officer)Norman L. Shipley(Executive Officer, Director)

Co-investorsAsset Management CompanyBrightspark VenturesCrosslink CapitalDataTribeDifferential VenturesF-Prime Capital+11 more

Cerevancecerevance.comin𝕏Series B · Feb 2023 · $51M

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US

Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in

Co-investorsDementia Discovery FundForesite CapitalGV (Google Ventures)SV Life SciencesDementia DiscoveryDolby Family Ventures+3 more

Claret Medicalclaretmedical.comSeries B · Aug 2014 · $18M

HealthtechSanta Rosa, US

Fred Khosravi(Director)Tony Fields(Executive Officer)

BoardJames Eadie(Director)Azin Parhizgar(Executive Officer, Director)inHenry A. Plain(Director)Leo Nelson Hopkins(Director)

Co-investors415 CapitalLightstone VenturesEaston CapitalSante Ventures

Earlensearlens.comOct 2018 · $87M

Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.

HardwareHealthtechMedical DevicesMenlo Park, US

Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)Brent Edwards(Executive Officer)Greg Koskowich(Executive Officer)

Co-investorsAisling CapitalNew Enterprise Associates (NEA)Windham Capital PartnersLightstone VenturesSightLine Partners

Evernoteevernote.comin𝕏Acquired

Evernote is a note-taking and productivity platform that helps individuals and teams capture, organize, and access information across devices.

AI & Machine LearningSaaS

Eric Libin(Founder & CEO)

Co-investorsCanvas VenturesCoatue ManagementEastlink Capital PartnersFelicis VenturesGlynn Capital ManagementNew Enterprise Associates (NEA)+9 more

JasperSoftjaspersoft.comacquired by TIBCO

Jaspersoft offers a reporting and embedded analytics platform that lets software teams build pixel-perfect reports, self-service ad hoc reporting, and data visualizations inside their own applications.

Data & InfrastructureEnterprise SoftwareSaaS

Al Campa(Founder)Raj Bhargava(Founder)

Co-investorsCanvas VenturesSapphire VenturesToba CapitalScale Venture PartnersWorld Innovation Lab (WiL)

LendingClubhappen.comin𝕏

Happen Bank originates and sells unsecured personal loans to institutional investors including banks, credit unions, and asset managers seeking high-yield, short-duration credit assets.

ConsumerEnterprise SoftwareFintechSector AgnosticLehi, US

Scott SanborninRenaud Laplanche(Founder)Soul Htite(Founder)

Co-investors3Spoke CapitalAlpaca VCCanaan PartnersCanvas VenturesCapitalGCoatue Management+16 more

Mosaicbiomosaicbio.comin

Mosaic Biosciences is a biologics discovery company that advances biologic drug candidates from discovery through IND-enabling studies and clinical development, working with partners across multiple therapeutic modalities.

BiotechDeep TechBoulder, US

Marty (Martin) Stanton(Founder & former CEO)inEric Furfine(Chief Scientific Officer)inAlexei Kazantsev(Vice President Protein Design and Engineering)inTracey Mullen(Chief Strategy Officer)inScott Glaser(SVP, Biologics Discovery)inJean-Pierre Wery(Chief Executive Officer)in

Co-investorsTelegraph Hill Partners

Moximedmoximed.com

HealthtechFremont, US

Anton Clifford(Executive Officer)inJames Leech(Executive Officer)inChristopher Gleason(Executive Officer)inKevin K. Sidow(Executive Officer, Director)

BoardJoshua Makower(Director)Shahzad Malik(Director)in

Co-investorsLightstone VenturesNew Enterprise Associates (NEA)Runway Growth CapitalAdvent Life SciencesGBS Venture Partners Ltd.Gilde Healthcare+1 more

Mulesoftmulesoft.comMay 2015Acquired

MuleSoft is a San Francisco enterprise software company providing integration, API management and automation via its Anypoint Platform.

San Francisco, US

Ross Mason(Founder)inGregory G. Schott(Executive Officer, Director)Matthew Langdon(Executive Officer)Robert Horton(Executive Officer)Michael DiFilippo(Executive Officer)Dave Rosenberg(Founder)

Co-investorsArtisanal VenturesCanvas VenturesCategory VenturesHummer Winblad Venture Partners (HWVP)IVP (Institutional Venture Partners)Lightspeed Venture Partners+13 more

Nominumnominum.com

Paul Mockapetris(Founder)

Nuvairanuvaira.comin𝕏Series A · May 2011 · $5M

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).

HardwareHealthtechMedical DevicesMinneapolis, US

Martin Mayse(Founder)inSteve Dimmer(Founder)inDennis Wahr(President & CEO)inLisa Flaherty(Chief Strategy Officer)inSteve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)

Co-investorsWindham Capital PartnersEndeavour VisionLightstone VenturesQiming Venture PartnersRichard King Mellon FoundationSplit Rock Partners+2 more

Principiaprincipia.netin

Principia is an operating system and integrated SaaS platform for educational institutions in Brazil, combining technology, payment methods, and financing to support the complete educational journey from planning to financial management.

AI & Machine LearningEdTechFintechSaaSSão Paulo, BR

Newton Maia(Founder)inDiogo Fonseca(Co-founder)in

Co-investorsValor Capital GroupCapria VenturesFJ Labs

Ra Pharmaceuticalsrapharma.com𝕏Jul 2015

UCB is a global biopharmaceutical company that develops medicines and treatment-support services for people living with neurological and autoimmune conditions, including rare diseases such as epilepsy.

BiotechHealthtechCambridge, US

Douglas A. Treco(Executive Officer, Director)Kerry Black(Executive Officer)in

BoardEdward Mathers(Director)Rajeev Shah(Director)inPeter Bisgaard(Director)Jason Lettman(Director)

Co-investorsLightstone VenturesNew Enterprise Associates (NEA)RA Capital

Relievant Medsystemsrelievant.comSeries C · Jul 2009 · $20M

Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.

Medical DevicesRedwood City, US

Alex DiNello(Executive Officer, Director)

BoardRichard Mott(Director)Justin Klein(Director)inBrent Ahrens(Director)inJason Lettman(Director)John Ryan(Director)

Co-investorsCanaan PartnersEmergent Medical Partners, LLPLightstone VenturesNew Enterprise Associates (NEA)Vensana Capital

Rhythm NewMediarhythmnewmedia.com

Rhythm connects brand advertisers with mobile audiences by selling video, rich media, and immersive advertising formats across a portfolio of 200+ premium media properties.

AdTechMarketing TechMedia & Entertainment

Co-investorsQuestMark PartnersLightspeed Venture PartnersRembrandt Venture PartnersUnion Grove Venture Partners

SetPoint Medicalsetpointmedical.comin𝕏Series C · Sep 2015 · $15M

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)inKevin Tracey(Founder)

BoardBlake Wu(Director)in

Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersAsahi Kasei Corporate Venture CapitalCatalio Capital Management, LP+8 more

Sonatypesonatype.comin𝕏

Sonatype provides software supply chain management and security solutions for managing open source software and AI dependencies.

CybersecurityDeveloper ToolsEnterprise SoftwareFulton, US

Brian Fox(Chief Technology Officer and co-founder)inWAYNE JACKSON(Executive Officer, Director)inDAVID C. MILLER(Executive Officer)

BoardANN WINBLAD(Director)inSAMEER GANDHI(Director)inMICHAEL O'DELL(Director)

Co-investorsAccelAspenwoodBlue Delta CapitalCanvas VenturesFounders Circle CapitalGolub Growth+6 more

Sonic Innovationssonici.com

Manufactures hearing solutions for people with hearing loss, sold primarily under the Oticon, Bernafon, Sonic, and Philips Hearing Solutions brands.

HardwareHealthtechMedical Devices

Co-investorsNew Enterprise Associates (NEA)Venrock

Spine Wavespinewave.comin

Spine Wave develops and commercializes expandable and minimally invasive surgical products for spine surgeons and their patients.

HealthtechMedical DevicesShelton, US

Mark D. LoGuidice(Executive Officer, Director)Terrence J. Brennan(Executive Officer)

BoardAndrew D. Firlik(Director)Marie-Helene Plais(Director)Jeff Samberg(Director)Ryan Drant(Director)

Co-investorsCalifornia Technology VenturesNew Enterprise Associates (NEA)Industry Ventures

The Foundrythefoundrytypes.com

The Foundry presents and licenses typefaces and font families used in print and design projects, including fonts such as Architype Bayer-Type, Foundry Plek, Foundry Sterling, Foundry Wilson, and Foundry Context.

Creator EconomyMedia & Entertainment

David Quay(Founder)Freda Sack(Founder)

Transcendtranscend.ioin𝕏

Transcend provides a real-time data governance and decision layer that encodes business policy, regulatory context, and customer permissions into systems processing customer data, answering "Can I use this data?" at runtime.

AI & Machine LearningCybersecurityData & InfrastructureSan Francisco, US

Ben Brook(Founder)inMichael Farrell(Founder)Mike Farrell(Founder)Rebekah Robertson(Founder)

Co-investors01 AdvisorsAccelIndex VenturesOctaveSouth Park CommonsChartline Capital Partners+8 more

Twelvetwelve.coin𝕏

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

Nicholas Flanders(Founder)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Co-investorsBreakout VenturesDCVC (Data Collective)Dolby Family VenturesFifth WallAdvantage Partners Inc.Aera VC+36 more

Vapothermvapotherm.comin𝕏Apr 2013 · $29M

Vapotherm manufactures high-velocity therapy devices for respiratory distress treatment across patient populations.

HardwareHealthtechMedical DevicesExeter, US

JOSEPH ARMY(Executive Officer, Director)JOHN LANDRY(Executive Officer)in

BoardANTHONY ARNERICH(Director)JASON LETTMAN(Director)GEOFF PARDO(Director)inSAMUEL BRASCH(Director)

Co-investorsCross Creek AdvisorsKaiser Permanente VenturesQuestMark Partners3x5 PartnersGilde Healthcare

Vitessevitesse.io

Vitesse provides financial infrastructure for the insurance industry, enabling insurers, MGAs, TPAs, brokers and capacity providers to hold and safeguard premium and claim funds, gain real-time visibility, and make instant or same-day payments to claimants and suppliers globally.

FintechInsurTechSaaS

Paul Townsend(Founder)Phillip McGriskin(Founder)

Co-investorsHoxton VenturesPrime Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AneuRxAtsena TherapeuticsCardioThoracic SystemsCatalyst BiosciencesCortina SystemsFundlyKona MedicalMiramar LabsNuance CommunicationsSocrataTimesTen

Exits · 5

2 IPOs · 3 acquisitions · showing 3

DoximityNYSE: DOCSEBR SystemsOTC: EBRCZJasperSoftacq. by TIBCO

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Morgenthaler made?
Morgenthaler has 40 tracked investments, 5 of which have exited.
What stage does Morgenthaler invest at?
Morgenthaler invests at the Pre-Seed, Seed, Series A, Series B, Series C stages.
What sectors does Morgenthaler focus on?
Morgenthaler focuses on Biotech, Sector Agnostic.
Where is Morgenthaler located?
Morgenthaler is headquartered in Portola Valley, US.

Media · Podcasts & interviews

featuring the team

Rebecca Lynn, Morgenthaler @SFVentureSummit2011

SVTV · Rebecca Lynn

Co-investors · 30

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

$200K – $40M
Lightstone Ventures

Lightstone Ventures is a life sciences venture firm founded in 2012 that invests in biotech and medtech companies, backing founders translating scientific breakthroughs into therapies and medical technologies.

Norwest Venture Partners

Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.

$10M – $30M
Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M
Meritech Capital Partners

Meritech Capital Partners is a venture capital firm, founded in 1999, that invests in market-leading technology companies, having backed 200+ investments with 60+ IPOs.

Both backed · 2
$5M – $40M
Sofinnova Ventures

Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.

Both backed · 2
Atsena TherapeuticsCatalyst Biosciences
$100K – $15M
Aisling Capital

Aisling Capital is an investment firm focused on companies developing and commercializing innovative healthcare products, services, and technologies.

Both backed · 2
GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

Both backed · 1
$250K – $50M
Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

Both backed · 1
$100K – $20M
SR One Capital Management

SR One Capital Management is a life sciences venture capital firm that takes a 'back-and-build' approach, providing entrepreneurs with human, intellectual, and financial resources. It emerged from the legacy SR One team formerly part of GSK.

Both backed · 1
Second Genome
Abingworth

Abingworth is a life science venture capital firm that backs early-stage biopharma and biotech companies, helping entrepreneurs translate scientific discoveries into new therapeutics.

Both backed · 1
Atsena Therapeutics
$15M – $30M
Roche Venture Fund

Roche Venture Fund is a corporate venture arm that invests in early-stage biotech and diagnostics companies across more than 10 countries, with a portfolio exceeding 30 portfolio companies. The fund is headquartered in Basel, Switzerland.

Both backed · 1
Second Genome
$648K – $3.2M
▶18 more co-investors

Vensana CapitalAction Potential Venture Capital Ltd.ShangBay Capital LLCBessemer Venture PartnersRedpoint VenturesMenlo VenturesHanabi CapitalAccompliceDell Technologies CapitalTenaya CapitalThird Point VenturesvenBio PartnersCervinMoment Ventures, LlcTwo Bear CapitalMedical Excellence CapitalTriplePoint CapitalMohr Davidow Ventures

Firms observed investing alongside Morgenthaler, from public investor directories. Shared companies are the overlap with Morgenthaler's recorded portfolio.

Similar investors

Featured in lists